Home/ Supplements/ Niacin/ Pure-X7

Pure-X7

product on market Capsule Image Sports Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Niacin is well-studied for supporting energy metabolism, though evidence for the proprietary PURE-X7 Burning Blend is limited. Research on individual thermogenic components typically shows moderate effects on metabolic rate. Overall evidence coverage for this specific formulation is minimal.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Pure-X7
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
36
Servings
Other Combinations
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

25 mg (125% DV)
1.8× RDA — within safe limits 196 studies (A:5, B:63)
PURE-X7(TM) BURNING BLEND
525 mg

Other Ingredients

Gelatin Microcrystalline Cellulose Silica Magnesium Stearate Stearic Acid FD&C Blue No. 1 FD&C Red No. 40 Titanium Dioxide
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Additional Information

Rev. 01-002-PX7001 04/13

SUPER CONCENTRATED THERMOGENIC*

CNS STIMULANT MAY EXPERIENCE: INTENSE ENERGY* WEIGHT LOSS*

20% FREE

Please read entire label before use.

CNS STIMULANT

Metadata

Product Details

UPC / SKU8 59123 00393 7
DSLD Entry Date2014-05-23
Product TypeOther Combinations
FormCapsule
DSLD ID33210
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.